Abiopharma

🔍 Field Dylan (Executive)

Company: Figma, Inc. (FIG)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Acquired 5 shares of Class A Common Stock (Direct)
  Date: 2026-03-18 | Code: J | equity_swap_involved: 0 | shares_owned_after: 5.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 153 shares of Class A Common Stock (Direct)
  Date: 2026-03-18 | Code: J | equity_swap_involved: 0 | shares_owned_after: 153.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: Represents shares of Class A Common Stock received pursuant to a pro rata distribution by Goanna Capital Fund I, LP, for no consideration, to its partners. The distribution was made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.
• F2: Represents shares of Class A Common Stock received pursuant to a pro rata distribution by Goanna Capital Private Technology II, LP, for no consideration, to its partners. The distribution was made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.
• F3: These shares are held of record by Field Family Investments LLC, which is associated with the Reporting Person.